← Latest papers
📄 chemistry

A noncanonical PLP-dependent enzyme catalyzes β-serine biosynthesis in the edeine antibiotic pathway

This study identifies and characterizes EdeM, a noncanonical PLP-dependent enzyme that catalyzes the unprecedented intramolecular rearrangement of L-serine to produce enantiomerically pure D-β-serine for edeine antibiotic biosynthesis, thereby expanding the known catalytic repertoire of PLP enzymes.

Original authors: Gerard Wright, Andrea Benediktsdottir, Haley Zubyk, Kalinka Koteva, Erica Muscat, Brandon White, Jacob Walsh, Erin Westman, Travis Dudding, Sara Andres

Published 2026-10-29
📖 6 min read🧠 Deep dive

Original authors: Gerard Wright, Andrea Benediktsdottir, Haley Zubyk, Kalinka Koteva, Erica Muscat, Brandon White, Jacob Walsh, Erin Westman, Travis Dudding, Sara Andres

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

Life on Earth relies on a set of twenty standard building blocks to construct the proteins that drive every biological process. These are the alpha-amino acids, where a central carbon atom holds an amino group, a carboxyl group, and a side chain. However, nature occasionally reaches beyond this standard set, incorporating unusual variants into specialized molecules like antibiotics. One such variant is the beta-amino acid, where the amino group is attached to the second carbon in the chain rather than the first. This small shift in position changes the molecule's shape and stability, making it resistant to the enzymes that usually break down proteins. While scientists have long known how bacteria create some of these beta-amino acids, the method used to produce a specific one called D-beta-serine has remained a mystery, leaving a gap in our understanding of how certain powerful antibiotics are assembled.

A team of researchers at McMaster University and Brock University has now solved this puzzle by identifying and characterizing a specific enzyme named EdeM. This enzyme is responsible for creating D-beta-serine in the pathway that produces edeine, a peptide antibiotic made by a soil bacterium called Brevibacillus brevis. The discovery is significant because EdeM performs a chemical transformation that had never been seen before in this family of enzymes. While most enzymes of this type work by swapping parts between two different molecules, EdeM takes a single molecule of the common amino acid L-serine and rearranges its internal structure to create the beta version. It does this without needing a second molecule to accept or donate parts, and it does so with perfect precision, producing only one specific 3D shape of the product.

The researchers began by looking at the genetic instructions for making edeine. They found a gene, edeM, that looked very similar to genes for enzymes known as aminotransferases. These standard enzymes typically act like molecular scissors and glue, cutting an amino group off one molecule and attaching it to another. To test what EdeM actually did, the team produced the enzyme in the lab and mixed it with L-serine. They found that EdeM converted the L-serine into D-beta-serine all by itself, without adding any other chemical partners. This was unexpected, as the standard model for these enzymes requires two different substrates to work. Further experiments showed that EdeM is extremely picky; it only works on L-serine and ignores other similar amino acids.

To understand how this single-substrate reaction happens, the scientists needed to see exactly what was moving inside the enzyme. They grew crystals of EdeM and used X-rays to map its atomic structure. The enzyme looked like a typical aminotransferase, built from two identical halves that form a pocket where the reaction occurs. Inside this pocket, they found a helper molecule called PLP, which acts as a chemical anchor for the amino acid. The structure revealed that the enzyme relies heavily on four specific tyrosine residues, which are amino acids with hydroxyl groups, to hold the substrate in place. When the researchers mutated these tyrosines, the enzyme stopped working, proving they are essential for this unique reaction.

The team then used a series of clever experiments to trace the path of the atoms as the reaction occurred. They used water containing a heavy version of oxygen to see if the enzyme broke the molecule apart and reassembled it with water, a common step in many chemical reactions. The results showed no incorporation of the heavy oxygen, ruling out the standard mechanism where the molecule is cut and hydrolyzed. They also used carbon dioxide labeled with a heavy isotope to see if the enzyme released carbon dioxide and then grabbed a new one from the air. The product contained only the original carbon from the starting material, proving that the carbon dioxide was never released into the surrounding solution.

The most revealing clues came from tracking the movement of carbon atoms and hydrogen atoms. By using L-serine where the carbon atoms were labeled, they discovered that the carbon atom originally at the second position in the chain moved to the third position in the final product. Simultaneously, the carboxyl group, which was attached to the first carbon, moved to the new third position. This meant the entire carbon skeleton of the molecule had rearranged itself. Further tests with heavy hydrogen showed that two hydrogen atoms were added to the new position, confirming that the reaction involved a specific migration of the carboxyl group from one end of the molecule to the other.

To explain how this migration happens, the researchers turned to computer simulations. They modeled the reaction inside the enzyme's active site and tested two possible pathways. One idea involved the molecule forming a temporary, highly strained three-membered ring, similar to a twisted triangle, before opening up again. While the computer showed this shape could exist, it could not find a clear path for the reaction to get there. The other model involved a direct, smooth slide of the carboxyl group from one carbon to the next, a process known as a 1,2-migration. The simulations showed that this direct path had a very low energy barrier, meaning it could happen easily, and the specific tyrosine residues in the enzyme acted like a scaffold to stabilize the moving parts during the shift. This 1,2-migration mechanism fits all the experimental data, explaining how the enzyme moves the carboxyl group without breaking the molecule apart or releasing carbon dioxide.

This discovery reveals a new way that nature can manipulate amino acids. EdeM expands the known capabilities of PLP-dependent enzymes, showing they can perform complex internal rearrangements without the usual partners or steps. The enzyme produces D-beta-serine with perfect stereochemical control, creating a single, pure form of the molecule. Interestingly, the final edeine antibiotic contains the L-form of beta-serine, suggesting that another enzyme must flip the shape of the molecule after EdeM makes it, a step that remains to be discovered. By defining this unique enzymatic route, the study provides a blueprint for how bacteria build complex antibiotics and offers a new tool for scientists who wish to create similar molecules for medical use. The work highlights the incredible versatility of biological catalysts, which can evolve to perform chemical feats that were previously thought impossible.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →